These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8732338)

  • 1. Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2.
    Miles DW; Happerfield LC; Bobrow LG; Rubens RD
    Histopathology; 1996 Apr; 28(4):301-8. PubMed ID: 8732338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation.
    Vyth-Dreese FA; Dellemijn TA; Frijhoff A; van Kooyk Y; Figdor CG
    Eur J Immunol; 1993 Dec; 23(12):3292-9. PubMed ID: 7903074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.
    Cotran RS; Pober JS; Gimbrone MA; Springer TA; Wiebke EA; Gaspari AA; Rosenberg SA; Lotze MT
    J Immunol; 1988 Mar; 140(6):1883-8. PubMed ID: 3279124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells.
    Beekhuizen H; Corsèl-Van Tilburg AJ; Blokland I; Van Furth R
    Immunology; 1991 Dec; 74(4):661-9. PubMed ID: 1723715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of ICAM-1 and VCAM-1 to the morphological changes in monocytes bound to human venous endothelial cells stimulated with recombinant interleukin-4 (rIL-4) or rIL-1 alpha.
    Beekhuizen H; Verdegaal EM; Blokland I; van Furth R
    Immunology; 1992 Nov; 77(3):469-72. PubMed ID: 1282495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of malignant haemangioendothelioma treated with recombinant interleukin-2.
    Ansai S; Goto K; Aoki T; Hozumi Y; Aso K
    Clin Exp Dermatol; 1993 Sep; 18(5):470-5. PubMed ID: 8252775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects.
    Hermann GG; Geertsen PF; von der Maase H; Steven K; Andersen C; Hald T; Zeuthen J
    Cancer Res; 1992 Feb; 52(3):726-33. PubMed ID: 1732060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
    Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
    Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques.
    Wakita H; Takigawa M
    Arch Dermatol; 1994 Apr; 130(4):457-63. PubMed ID: 7513146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells.
    Wang X; Feuerstein GZ; Gu JL; Lysko PG; Yue TL
    Atherosclerosis; 1995 May; 115(1):89-98. PubMed ID: 7545398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of continuous infusion of recombinant interleukin-2.
    West WH
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 3():S11-5. PubMed ID: 2627985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice.
    Anderson JA; Lentsch AB; Hadjiminas DJ; Miller FN; Martin AW; Nakagawa K; Edwards MJ
    J Clin Invest; 1996 Apr; 97(8):1952-9. PubMed ID: 8621780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hemangioendothelioma.
    Ihda H; Tokura Y; Fushimi M; Yokote R; Hashizume H; Shirahama S; Iwatsuki K; Murakami K; Takigawa M
    Int J Dermatol; 1995 Nov; 34(11):811-6. PubMed ID: 8543420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the immune system of cancer patients by continuous i.v. recombinant IL-2 (rIL-2) therapy is dependent on dose and schedule of rIL-2.
    Gratama JW; Bruin RJ; Lamers CH; Oosterom R; Braakman E; Stoter G; Bolhuis RL
    Clin Exp Immunol; 1993 May; 92(2):185-93. PubMed ID: 8485906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelial leukocyte adhesion molecule-1 and platelet-activating factor in neutrophil adherence to IL-1-prestimulated endothelial cells. Endothelial leukocyte adhesion molecule-1-mediated CD18 activation.
    Kuijpers TW; Hakkert BC; Hoogerwerf M; Leeuwenberg JF; Roos D
    J Immunol; 1991 Aug; 147(4):1369-76. PubMed ID: 1714481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis).
    Griffiths CE; Barker JN; Kunkel S; Nickoloff BJ
    Br J Dermatol; 1991 Jun; 124(6):519-26. PubMed ID: 1712219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.